AN2 Therapeutics, Inc. (ANTX): SCHEDULE 13G filed Jun 4, 2025

Form type

SCHEDULE 13G

Filing date

Jun 4, 2025

Accession number

0000935836-25-000414

Filer

AN2 Therapeutics, Inc. (CIK 1880438)